Literature DB >> 9690981

Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.

B Finkel1, A Lerner, I Oyffe, D Rudinski, M Sigal, A Weizman.   

Abstract

Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690981     DOI: 10.1097/00004850-199805000-00007

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  3 in total

1.  A case of neutropenia and thrombocytopenia shortly after initiaing olanzapine.

Authors:  Aditi Mehta; John Sanitato
Journal:  Psychiatry (Edgmont)       Date:  2005-09

Review 2.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study.

Authors:  Lun Yang; Kejian Wang; Jian Chen; Anil G Jegga; Heng Luo; Leming Shi; Chunling Wan; Xizhi Guo; Shengying Qin; Guang He; Guoyin Feng; Lin He
Journal:  PLoS Comput Biol       Date:  2011-03-31       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.